Tharimmune, Inc. (THAR), a clinical-stage biotechnology company, on Friday announced that it has appointed Jacob Asbury as Chief Financial Officer with immediate effect.
Asbury will oversee all the financial strategy and operations, which include planning, treasury management, financial reporting, and the pension of its CC treasury infrastructure.
Asbury brings around 20 years of financial leadership and held CFO roles previously at Clear Street Group, Inc., Performance Flight & Custom Jet Charters, and Instinet Inc.
In the pre-market trading, Tharimmune is 1.58% higher at $2.5700 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.